RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,659 | -61.9% | 9,869 | -54.5% | 0.00% | -100.0% |
| Q2 2023 | $27,985 | +174806.2% | 21,694 | +78.1% | 0.00% | 0.0% |
| Q1 2023 | $16 | -33.3% | 12,180 | -24.8% | 0.00% | 0.0% |
| Q4 2022 | $24 | -99.9% | 16,188 | -50.8% | 0.00% | 0.0% |
| Q3 2022 | $39,000 | -68.5% | 32,878 | -70.1% | 0.00% | -66.7% |
| Q2 2022 | $124,000 | +55.0% | 109,944 | +314.7% | 0.00% | +200.0% |
| Q1 2022 | $80,000 | -50.6% | 26,512 | -56.7% | 0.00% | -66.7% |
| Q4 2021 | $162,000 | +33.9% | 61,234 | +82.8% | 0.00% | 0.0% |
| Q3 2021 | $121,000 | +120.0% | 33,491 | +160.8% | 0.00% | +200.0% |
| Q2 2021 | $55,000 | -5.2% | 12,840 | -25.2% | 0.00% | 0.0% |
| Q1 2021 | $58,000 | +52.6% | 17,157 | +57.9% | 0.00% | 0.0% |
| Q4 2020 | $38,000 | -93.1% | 10,863 | -95.2% | 0.00% | -83.3% |
| Q3 2020 | $547,000 | +728.8% | 227,819 | +528.7% | 0.01% | +100.0% |
| Q2 2020 | $66,000 | – | 36,236 | +47578.9% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 76 | -94.4% | 0.00% | – |
| Q3 2019 | $3,000 | – | 1,364 | +1768.5% | 0.00% | – |
| Q2 2019 | $0 | – | 73 | -47.9% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 140 | -99.3% | 0.00% | -100.0% |
| Q2 2018 | $56,000 | +75.0% | 19,584 | +116.2% | 0.00% | 0.0% |
| Q1 2018 | $32,000 | -34.7% | 9,059 | -53.3% | 0.00% | -25.0% |
| Q3 2017 | $49,000 | +36.1% | 19,383 | +18.8% | 0.00% | +33.3% |
| Q2 2016 | $36,000 | +24.1% | 16,314 | +38.4% | 0.00% | 0.0% |
| Q3 2015 | $29,000 | +314.3% | 11,791 | +416.9% | 0.00% | +200.0% |
| Q2 2015 | $7,000 | -88.9% | 2,281 | -87.2% | 0.00% | -87.5% |
| Q1 2015 | $63,000 | +43.2% | 17,751 | -22.3% | 0.01% | +60.0% |
| Q3 2014 | $44,000 | – | 22,832 | +48478.7% | 0.01% | – |
| Q2 2014 | $0 | -100.0% | 47 | -98.9% | 0.00% | -100.0% |
| Q4 2013 | $12,000 | +1100.0% | 4,321 | +2426.9% | 0.00% | – |
| Q3 2013 | $1,000 | -85.7% | 171 | -91.5% | 0.00% | -100.0% |
| Q2 2013 | $7,000 | – | 2,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |